Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...
Just kidding, all you need to do is click your mouse, and your avatar will do all the walking in the Maze Simulator. You can never be entirely sure you’ve typed in a code correctly if you’re ...
Awesome Games Done Quick will let the most talented speedrunners compete for a good cause. / Awesome Games Done Quick via X.com While much attention is given to multiplayer games in esports ...
Just a month after announcing a $115 million series D financing to advance its lead assets, Maze Therapeutics is looking to boost its kidney disease candidates further by going public. The Bay ...
[Notice] This list is not being maintained anymore because of the overwhelming amount of deep learning papers published every day since 2017. A curated list of the most cited deep learning papers ...